Pharming Adds CDZ173 To Its Rare Disease Pipeline, Foresees Launch by 2022

 
• By Sten Stovall
  
Add_To_Cart
CDZ173 is in late-stage trials for treating APDS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip